Back to Companies
Mineralys Therapeutics, Inc.
MLYSNasdaqCIK: 0001933414
Mineralys Therapeutics, Inc. (MLYS) shows 50 recent insider filings from 10 insiders, with 2 buying and 7 selling. With $45.0M in purchases and $85.8M in sales, the recent tape is net selling (net sales of $40.8M). Slingsby Brian Taylor (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $43.4M by Slingsby Brian Taylor. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$149.7M
Purchases
$45.0M
Sales
$85.8M
Unique Insiders
10
Recent Insider Trades
50 loaded
| Aug 12 | MLYS Mineralys Therapeutics, Inc. | Ferguson James J. III | Chief Medical Officer | Other | $0 |
| Aug 12 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $58.8K |
| Aug 12 | MLYS Mineralys Therapeutics, Inc. | Ferguson James J. III | Chief Medical Officer | Grant | $3.7M |
| Jul 23 | MLYS Mineralys Therapeutics, Inc. | Warren Eric | Chief Commercial Officer | Sell | $199.9K |
| Jul 20 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $11.0K |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $556.7K |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $291.4K |
| Jul 10 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $65.8K |
| Jun 30 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $2.0M |
| Jun 30 | MLYS Mineralys Therapeutics, Inc. | Warren Eric | Chief Commercial Officer | Sell | $2.7M |
| Jun 17 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $75.0K |
| Jun 17 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $350.1K |
| Jun 12 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $206.2K |
| May 19 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $11.5K |
| May 13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $652.6K |
| Apr 21 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $13.0K |
| Apr 15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $548.7K |
| Apr 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $422.0K |
| Apr 13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $59.4K |
| Apr 2 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $75.0K |
| Apr 2 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $2.0M |
| Mar 17 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $10.7K |
| Mar 16 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $543.0K |
| Mar 10 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $58.3K |
| Mar 4 | MLYS Mineralys Therapeutics, Inc. | Warren Eric | Chief Commercial Officer | Other | $0 |
| Feb 17 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $11.5K |
| Feb 11 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $65.6K |
| Jan 20 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $13.4K |
| Jan 15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $623.1K |
| Jan 13 | MLYS Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | Sell | $345.7K |
| Jan 13 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $529.6K |
| Jan 13 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $277.3K |
| Jan 6 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $9.3M |
| Nov 24 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Exercise | $13.0K |
| Nov 21 | MLYS Mineralys Therapeutics, Inc. | Slingsby Brian Taylor | Director, 10% Owner | Sell | $43.4M |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Karydas Daphne | Director | Sell | $689.8K |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | Sell | $5.4M |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Gold Alexander M | Director | Sell | $1.6M |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $9.1M |
| Oct 15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $446.0K |
| Oct 15 | MLYS Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | Sell | $452.0K |
| Oct 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $644.3K |
| Sep 16 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $409.3K |
| Sep 8 | MLYS Mineralys Therapeutics, Inc. | AKKARAJU SRINIVAS | Insider | Buy | $15.0M |
| Sep 8 | MLYS Mineralys Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | Insider | Buy | $30.0M |
| Aug 14 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $147.0K |
| Jul 30 | MLYS Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | Sell | $1.1M |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Sell | $165.9K |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $230.4K |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Levy Adam Scott | CFO and Secretary | Sell | $155.5K |
50 filings